Differential Tumor Progression Patterns in Skull Base Versus Non–Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature-Reference-Cited by-同舟云学术

Differential Tumor Progression Patterns in Skull Base Versus Non–Skull Base Meningiomas: A Critical Analysis from a Long-Term Follow-Up Study and Review of Literature

Published:2018-04 Issue: Volume:112 Page:e74-e83
ISSN:1878-8750
Container-title:World Neurosurgery
language:en
Short-container-title:World Neurosurgery

Author:

Savardekar Amey R.,Patra Devi Prasad,Bir Shyamal,Thakur Jai Deep,Mohammed Nasser,Bollam Papireddy,Georgescu Maria-Magdalena,Nanda Anil^ORCID

Publisher

Elsevier BV

Subject

Neurology (clinical),Surgery

Reference25 articles.

1. A comparison of World Health Organization tumor grades at recurrence in patients with non-skull base and skull base meningiomas;McGovern;J Neurosurg,2010

2. Recurrence and outcome in skull base meningiomas: do they differ from other intracranial meningiomas?;Nanda;Skull Base,2008

3. Long-term surgical outcome and biological prognostic factors in patients with skull base meningiomas;Ohba;J Neurosurg,2011

4. Slower growth of skull base meningiomas compared with non-skull base meningiomas based on volumetric and biological studies;Hashimoto;J Neurosurg,2012

5. Surgically resected skull base meningiomas demonstrate a divergent postoperative recurrence pattern compared with non-skull base meningiomas;Mansouri;J Neurosurg,2016

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Single versus multiple reoperations for recurrent intracranial meningiomas;Journal of Neuro-Oncology;2024-04-24

2. Interdisciplinary Therapeutic Approaches to Atypical and Malignant Meningiomas;Cancers;2023-08-25

3. The Current Landscape of Immune Checkpoint Inhibitor Immunotherapy for Primary and Metastatic Brain Tumors;Antibodies;2023-04-04

4. Symptom burden and surgical outcome in non-skull base meningiomas;Frontiers in Oncology;2022-09-21

5. Matched Paired Primary and Recurrent Meningiomas Points to Cell-Death Program Contributions to Genomic and Epigenomic Instability along Tumor Progression;Cancers;2022-08-19